Auna (AUNA) Stock Price, News & Analysis

Company Overview

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines. Its diagnostic division provides advanced imaging and laboratory testing, while its network of optical and dental clinics addresses routine and corrective needs. Auna also places an emphasis on patient experience, employing digital tools such as online appointment scheduling and telemedicine consultations to streamline access to care.

Formed in 2018 through the consolidation of several regional healthcare operators, Auna has expanded its footprint throughout Peru’s major urban centers. Headquartered in Lima, the company continues to invest in facility upgrades and technology enhancements to meet growing demand for private healthcare services. Under its executive management team, Auna has prioritized the integration of healthcare delivery systems and the development of digital health platforms to support long-term growth and operational efficiency.

Key Stats

• Today's Range: $4.90 to $4.98
• 50-Day Range: $4.16 to $5.97
• 52-Week Range: $4.09 to $6.85
• Volume: 251,302 shs
• Average Volume: 437,134 shs
• Market Capitalization: $365.24 million
• P/E Ratio: 18.98
• Dividend Yield: N/A
• Price Target: $6.97
• Consensus Rating: Hold

Auna Stock Analysis - MarketRank™

Auna scored higher than 96% of companies evaluated by MarketBeat, and ranked 24th out of 862 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

Auna has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and 1 sell rating.

Upside Potential

Auna has a consensus price target of $6.97, representing about 41.2% upside from its current price of $4.94.

Amount of Analyst Coverage

Auna has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 20.99%

Earnings Growth

Earnings for Auna are expected to grow by 20.99% in the coming year, from $0.81 to $0.98 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Auna is 18.98, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 43.23.

Price to Earnings Ratio vs. Sector

The P/E ratio of Auna is 18.98, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.48.

Price to Book Value per Share Ratio

Auna has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.29% of the float of Auna has been sold short.

Short Interest Ratio / Days to Cover

Auna has a short interest ratio ("days to cover") of 1.66, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Auna has recently increased by 24.56%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Auna does not currently pay a dividend.

Dividend Growth

Auna does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 2.9 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $283,779.00 in company stock, which represents 0.0777% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Auna insiders have bought 387.23% more of their company's stock than they have sold. Specifically, they have bought $357,063.00 in company stock and sold $73,284.00 in company stock.

Percentage Held by Institutions

Auna has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/15/2026
• Today: 6/13/2026
• Next Earnings (Estimated): 8/18/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:AUNA
• Previous Symbol: NYSE:AUNA
• CIK: 1799207
• Web: aunainvestors.com
• Phone: 512053500
• Fax: N/A
• Employees: 15,254
• Year Founded: 2008

Price Target and Rating

• Average Price Target for Auna: $6.97
• High Price Target: $9.00
• Low Price Target: $5.00
• Potential Upside/Downside: +41.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.26
• Trailing P/E Ratio: 18.98
• Forward P/E Ratio: 6.09
• P/E Growth: N/A
• Net Income: $27.39 million
• Net Margins: 1.53%
• Pretax Margin: 3.38%
• Return on Equity: 16.25%
• Return on Assets: 4.03%

Debt

• Debt-to-Equity Ratio: 1.76
• Current Ratio: 1.09
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: $1.23 billion
• Price / Sales: 0.30
• Cash Flow: $1.97 per share
• Price / Cash Flow: 2.51
• Book Value: $6.70 per share
• Price / Book: 0.74

Miscellaneous

• Outstanding Shares: 74,010,000
• Free Float: N/A
• Market Cap: $365.24 million
• Optionable: N/A
• Beta: 0.81